Search research articles
Contact Us
Filters
Showing results (31-40 of 269) with videos related to
Page
of 27
Sort By:
Gut
|
January 19, 2007
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire, Maja Noman, Gert Van Assche, et al.
Journal of Crohn'S & Colitis
|
August 22, 2025
Transmural healing in ulcerative colitis patients improves long-term outcomes compared to endoscopic healing alone
Chong-Teik Lim, Christoph Teichert, Maarten Pruijt, et al.
Gastrointestinal Endoscopy
|
May 26, 2015
Assessment of mucosal healing in inflammatory bowel disease: review
Parambir S Dulai, Barrett G Levesque, Brian G Feagan, et al.
British Journal of Clinical Pharmacology
|
May 17, 2020
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease
Erwin Dreesen, Sophie Berends, David Laharie, et al.
Inflammatory Bowel Diseases
|
September 15, 2021
Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease
Floris De Voogd, Harshad Joshi, Elsa Van Wassenaer, et al.
Gastrointestinal Endoscopy
|
January 30, 2008
Endoscopic trimming of metallic stents with the use of argon plasma
Paul Christiaens, Sofie Decock, Otto Buchel, et al.
United European Gastroenterology Journal
|
June 12, 2014
Fistulizing Crohn's disease: Diagnosis and management
Krisztina Gecse, Reena Khanna, Jaap Stoker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 30, 2021
Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn's Disease in the CELEST Extension Study
Geert D'Haens, Julian Panés, Edouard Louis, et al.
Expert Review of Gastroenterology & Hepatology
|
May 26, 2025
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease
Stephen B Hanauer, Byong Duk Ye, Raymond K Cross, et al.
Inflammatory Intestinal Diseases
|
December 1, 2025
Comparative Efficacy of Mesalazine and Ozanimod following Induction Treatment in Mesalazine-Exposed Advanced Therapy-Naïve Adult Ulcerative Colitis Patients
Geert D'Haens, Ekaterina Safroneeva, Laurent Peyrin-Biroulet, et al.
Page
of 27
Search research articles
Search
Showing results (31-40 of 269) with videos related to
Sort By:
Page
of 27
Gut
|
January 19, 2007
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire, Maja Noman, Gert Van Assche, et al.
Journal of Crohn'S & Colitis
|
August 22, 2025
Transmural healing in ulcerative colitis patients improves long-term outcomes compared to endoscopic healing alone
Chong-Teik Lim, Christoph Teichert, Maarten Pruijt, et al.
Gastrointestinal Endoscopy
|
May 26, 2015
Assessment of mucosal healing in inflammatory bowel disease: review
Parambir S Dulai, Barrett G Levesque, Brian G Feagan, et al.
British Journal of Clinical Pharmacology
|
May 17, 2020
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease
Erwin Dreesen, Sophie Berends, David Laharie, et al.
Inflammatory Bowel Diseases
|
September 15, 2021
Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease
Floris De Voogd, Harshad Joshi, Elsa Van Wassenaer, et al.
Gastrointestinal Endoscopy
|
January 30, 2008
Endoscopic trimming of metallic stents with the use of argon plasma
Paul Christiaens, Sofie Decock, Otto Buchel, et al.
United European Gastroenterology Journal
|
June 12, 2014
Fistulizing Crohn's disease: Diagnosis and management
Krisztina Gecse, Reena Khanna, Jaap Stoker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 30, 2021
Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn's Disease in the CELEST Extension Study
Geert D'Haens, Julian Panés, Edouard Louis, et al.
Expert Review of Gastroenterology & Hepatology
|
May 26, 2025
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease
Stephen B Hanauer, Byong Duk Ye, Raymond K Cross, et al.
Inflammatory Intestinal Diseases
|
December 1, 2025
Comparative Efficacy of Mesalazine and Ozanimod following Induction Treatment in Mesalazine-Exposed Advanced Therapy-Naïve Adult Ulcerative Colitis Patients
Geert D'Haens, Ekaterina Safroneeva, Laurent Peyrin-Biroulet, et al.
Page
of 27